Committed to your wellbeing

Spravato® may be an option for you. FDA-approved for treatment-resistant depression and for adults with major depression and suicidal thoughts, Spravato is a fast-acting nasal spray used alongside an oral antidepressant or as a monotherapy. It works differently than standard medications, offering new hope when others haven’t helped. Spravato is administered in a safe, comfortable setting under medical supervision—and the good news is, most insurance plans cover the cost of treatment. If you're ready for a new path to healing, ask us if Spravato is right for you. 

• What is Spravato?
  Spravato is a prescription nasal spray (esketamine) used along with an oral antidepressant to treat adults with treatment-resistant depression and those experiencing suicidal thoughts.
   
• How is Spravato given?
  It’s self-administered under the supervision of a healthcare provider in a certified clinic, where you’ll be monitored for about two hours after each dose.
   
• How often do I need treatment?
  Spravato is given twice a week during the first month, then less frequently during the maintenance phase based on your response and your doctor’s recommendation.
   
• Will I feel better right away?
  Some patients report improvement within hours or days, though results vary. Your provider will work closely with you to monitor your progress.
   
• Is it covered by insurance?
  Yes—most major insurance plans, including Medicare and commercial providers, cover Spravato treatment for eligible patients.
   
• What should I expect during treatment?
  You’ll rest in a quiet, supportive space while your provider monitors you. Many patients describe the experience as calming or introspective.
   
• Can I drive after a session?
  No. You’ll need someone to drive you home, as you may feel drowsy or disoriented for a few hours after treatment.
   

Let us know if you have more questions—we’re here to help you feel better.